Flomyst F Inhaler (125 mcg + 5 mcg)/puff is a fixed-dose combination inhalation therapy containing Fluticasone Propionate and Formoterol Fumarate, developed for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). This higher-strength formulation is suitable for patients who require enhanced anti-inflammatory control along with sustained bronchodilation.

Fluticasone Propionate is an inhaled corticosteroid that reduces airway inflammation, mucosal swelling, and mucus secretion. Formoterol Fumarate is a long-acting beta₂-agonist that relaxes bronchial smooth muscles, leading to prolonged bronchodilation. Together, they provide comprehensive symptom control and help prevent disease exacerbations when used regularly.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Flomyst F Inhaler (125 mcg + 5 mcg)/puff is indicated for:

• Maintenance treatment of bronchial asthma

• Long-term management of chronic obstructive pulmonary disease

• Prevention of asthma symptoms such as wheezing, chest tightness, and shortness of breath

• Reduction in the frequency and severity of asthma and COPD exacerbations

Pharmacological Action

Fluticasone Propionate exerts strong local anti-inflammatory effects in the lungs by inhibiting the release of inflammatory mediators and reducing airway hyperresponsiveness. Formoterol Fumarate stimulates beta₂-adrenergic receptors in bronchial smooth muscle, producing rapid and long-lasting bronchodilation. The combination improves lung function, airflow, and overall disease control when used as maintenance therapy.

Dosage and Administration

• Dosage is individualized based on disease severity and clinical response.

• Flomyst F Inhaler is administered via oral inhalation.

• Proper inhaler technique is essential for optimal therapeutic effect.

• The inhaler should be used regularly as prescribed and is not intended for immediate relief of acute symptoms.

• Patients should rinse their mouth after inhalation to reduce the risk of oral side effects.

Benefits

• Higher corticosteroid strength for better inflammation control

• Sustained bronchodilation for improved breathing

• Reduces asthma attacks and COPD flare-ups

• Convenient combination therapy in a single inhaler

• Suitable for long-term disease management

Side Effects

Common side effects may include:

• Throat irritation or hoarseness

• Headache

• Cough

• Oral fungal infections with prolonged use

These effects can usually be minimized by correct inhaler use and mouth rinsing after each dose.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Not recommended for relief of acute bronchospasm

• Use with caution in patients with cardiovascular disorders or active infections

• Regular medical monitoring is advised during long-term use

• Do not stop treatment abruptly without consulting a healthcare professional

Drug Interactions

Concomitant use with other beta-agonists, corticosteroids, or certain antifungal and antiviral drugs should be monitored. Patients should inform their physician about all medications they are taking.

Storage

Store below 30°C. Protect from heat, sunlight, and moisture. Keep out of reach of children.

Flomyst F Inhaler (125 mcg + 5 mcg)/puff provides effective, long-term control of asthma and COPD by targeting both airway inflammation and bronchoconstriction, helping patients breathe more comfortably and maintain better disease stability.